Your browser doesn't support javascript.
loading
Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.
Girnius, S; Seldin, D C; Meier-Ewert, H K; Sloan, J M; Quillen, K; Ruberg, F L; Berk, J L; Doros, G; Sanchorawala, V.
Afiliação
  • Girnius S; 1] Department of Medicine, Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA [2] Section of Hematology-Oncology, Department of Medicine, Boston Medical Center, Boston, MA, USA.
  • Seldin DC; 1] Department of Medicine, Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA [2] Section of Hematology-Oncology, Department of Medicine, Boston Medical Center, Boston, MA, USA.
  • Meier-Ewert HK; 1] Department of Medicine, Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA [2] Section of Cardiovascular Medicine, Department of Medicine, Boston Medical Center, Boston, MA, USA.
  • Sloan JM; 1] Department of Medicine, Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA [2] Section of Hematology-Oncology, Department of Medicine, Boston Medical Center, Boston, MA, USA.
  • Quillen K; 1] Department of Medicine, Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA [2] Section of Hematology-Oncology, Department of Medicine, Boston Medical Center, Boston, MA, USA [3] Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston, MA, USA.
  • Ruberg FL; 1] Department of Medicine, Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA [2] Section of Cardiovascular Medicine, Department of Medicine, Boston Medical Center, Boston, MA, USA.
  • Berk JL; 1] Department of Medicine, Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA [2] Section of Pulmonary, Critical Care, and Allergy, Department of Medicine, Boston Medical Center, Boston, MA, USA.
  • Doros G; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Sanchorawala V; 1] Department of Medicine, Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA [2] Section of Hematology-Oncology, Department of Medicine, Boston Medical Center, Boston, MA, USA.
Bone Marrow Transplant ; 49(3): 434-9, 2014 Mar.
Article em En | MEDLINE | ID: mdl-24317129
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco / Cardiopatias / Amiloidose / Melfalan Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco / Cardiopatias / Amiloidose / Melfalan Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos